We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Technology for Sampling Body Liquids in Confined Spaces to Enable Early Cancer Detection

By LabMedica International staff writers
Posted on 17 Sep 2024

Body fluids—such as blood, pancreatic juice, urine, and mucus—contain valuable information about chemical composition, biomarkers, bacterial colonies, and other key components. More...

This information aids researchers in understanding the mechanisms of various diseases, including cancer, and monitoring patients' health. Wireless mobile robots at the millimeter scale have shown promise in navigating confined spaces to collect these fluids due to their small size and agile movement. However, these devices have lacked the ability to sample liquids effectively because of the absence of efficient triggering and sealing mechanisms at such small scales. Researchers have now addressed this gap by developing technology for sampling body fluids in narrow and complex spaces, which could enable early detection of diseases like cancer.

A research team at Vanderbilt University (Nashville, TN, USA) has developed millimeter-scale soft capsules made of hydrogel-and-elastomer hybrids, which are controlled using external magnetic fields. These devices, according to the researchers, can be delivered and retrieved via a thin catheter and are capable of navigating tubular structures that are otherwise inaccessible to catheters. The soft capsules are coated with a specialized wetting property that enables them to efficiently pump liquids inside. As reported in Science Advances, the integration of on-demand triggering, sampling, and sealing mechanisms, along with agile group locomotion, allowed the team to demonstrate precise control of these soft capsules. They successfully navigated and sampled body fluids in a phantom and ex vivo animal organ, guided by ultrasound and X-ray medical imaging.

“The millimeter-scale soft capsules introduced in this work open avenues for minimally invasive and targeted liquid biopsy in confined spaces such as the pancreas duct, enabling early disease diagnosis and providing insights into disease development through the sampling, retrieval, and analysis of abundant chemicals within organs,” said Xiaoguang Dong, assistant professor of mechanical and biomedical engineering at Vanderbilt University, who led the research.

Related Links:
Vanderbilt University


New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
New
Repetitive Pipette
VWR® Stepper Pro
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The findings point to the feasibility of a quick, noninvasive urine-based approach to support earlier decision-making in multiple psychiatric conditions (photo credit: Shutterstock)

Noninvasive Urine Test May Support Earlier Diagnosis of Psychiatric Disorders

Delays in diagnosing serious psychiatric conditions can leave patients without timely support and complicate treatment planning. For bipolar disorder, average time to diagnosis can exceed nine years, and... Read more

Molecular Diagnostics

view channel
Image: The schematic diagram links key MASLD, MASH, and MASLD-HCC molecular drivers to emerging multi‑omics biomarkers and therapeutic modalities, highlighting the current barriers in clinical translation and strategic solutions aimed at refined risk stratification and personalized medicine (Photo courtesy of ©Science China Press)

Emerging Biomarkers Advance Early Detection of MASLD and Liver Cancer Risk

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects about 30% of people worldwide and can advance to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis, and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.